Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Aug 6;56(1):43.
doi: 10.1186/s13028-014-0043-5.

Efficacy of two low-dose oral tylosin regimens in controlling the relapse of diarrhea in dogs with tylosin-responsive diarrhea: a prospective, single-blinded, two-arm parallel, clinical field trial

Clinical Trial

Efficacy of two low-dose oral tylosin regimens in controlling the relapse of diarrhea in dogs with tylosin-responsive diarrhea: a prospective, single-blinded, two-arm parallel, clinical field trial

Susanne Kilpinen et al. Acta Vet Scand. .

Abstract

Background: Despite its wide acceptance as a treatment for canine chronic enteropathies, the macrolide antibiotic tylosin lacks official oral dosage recommendations. Not even textbooks share consensus about the dose; daily recommendations vary from 25 to 80 mg/kg and dosing intervals from one to three times daily.

Results: All eight dogs responded to the 5 mg/kg dose, and six of seven dogs responded to the 15 mg/kg dose. The mean fecal consistency scores at the 25 mg/kg tylosin dosage were no significantly different from scores at the 5 mg/kg or 15 mg/kg tylosin dosages (P=0.672, P=0.345).

Conclusions: Interestingly, 14/15 (93%) of the dogs responding to a dose of 25 mg/kg tylosin once daily for seven days also responded to the lower dosages at diarrhea relapse. The data indicate that a suitable dose of tylosin for treating diarrhea relapse in canine TRD could be as low as 5 mg/kg once daily for seven days.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the trial. Flowchart of the results of the study enrollment, the allocation to treatment groups, and the response to the two different tylosin dosages.
Figure 2
Figure 2
Mean fecal consistency scores per dog. Mean fecal consistency scores at dosages of 25 mg/kg (n = 15), 15 mg/kg (n = 7), and 5 mg/kg (n = 8) tylosin per dog assessed during the last three days of the seven-day treatment period.
Figure 3
Figure 3
Box and whisker plots of the mean fecal consistency scores. Box and whisker plots of the mean fecal consistency scores assessed during the last three days of the seven-day treatment period at tylosin dosages of 25 mg/kg (n = 15), 15 mg/kg (n = 7) and 5 mg/kg (n = 8). The limits of the box represent the 25th and 75th percentile values, the line within the box represents the median values and the whiskers represent the range. The black line indicates the cut-off value for a responder, set at a score of 3 on the mean fecal consistency score scale.

References

    1. Hall EJ. Antibiotic-responsive diarrhea in small animals. Vet Clin North Am Small Anim Pract. 2011;41:273–286. doi: 10.1016/j.cvsm.2010.12.004. - DOI - PubMed
    1. Hall EJ, German AJ. In: Textbook of Veterinary Internal Medicine. 7. Ettinger SJ, Feldman EC, editor. Elsevier Saunders, St Louis, MO; 2010. Diseases of the Small Intestine; pp. 1526–1572.
    1. Van Kruiningen HJ. Clinical efficacy of tylosin in canine inflammatory bowel disease. J Am Anim Hosp Assoc. 1976;12:498–501.
    1. Westermarck E, Myllys V, Aho M. Effect of treatment on the jejunal and colonic bacterial flora of dogs with exocrine pancreatic insufficiency. Pancreas. 1993;8:559–562. doi: 10.1097/00006676-199309000-00005. - DOI - PubMed
    1. Westermarck E, Skrzypczak T, Harmoinen J, Steiner JM, Ruaux CG, Williams DA, Eerola E, Sundbäck P, Rinkinen M. Tylosin-responsive chronic diarrhea in dogs. J Vet Intern Med. 2005;19:177–186. doi: 10.1111/j.1939-1676.2005.tb02679.x. - DOI - PubMed

Publication types